174 related articles for article (PubMed ID: 11290434)
1. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution.
D'Eredita' G; Giardina C; Martellotta M; Natale T; Ferrarese F
Eur J Cancer; 2001 Mar; 37(5):591-6. PubMed ID: 11290434
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.
Okugawa H; Yamamoto D; Uemura Y; Sakaida N; Yamada M; Tanaka K; Kamiyama Y
Surg Today; 2005; 35(11):907-11. PubMed ID: 16249842
[TBL] [Abstract][Full Text] [Related]
3. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.
Sundquist M; Thorstenson S; Brudin L; Nordenskjöld B
Breast Cancer Res Treat; 1999 Jan; 53(1):1-8. PubMed ID: 10206067
[TBL] [Abstract][Full Text] [Related]
4. The prognosis of small primary breast cancers.
Kollias J; Murphy CA; Elston CW; Ellis IO; Robertson JF; Blamey RW
Eur J Cancer; 1999 Jun; 35(6):908-12. PubMed ID: 10533470
[TBL] [Abstract][Full Text] [Related]
5. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).
Balslev I; Axelsson CK; Zedeler K; Rasmussen BB; Carstensen B; Mouridsen HT
Breast Cancer Res Treat; 1994; 32(3):281-90. PubMed ID: 7865856
[TBL] [Abstract][Full Text] [Related]
6. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.
Abdel-Fatah TM; Powe DG; Ball G; Lopez-Garcia MA; Habashy HO; Green AR; Reis-Filho JS; Ellis IO
J Pathol; 2010 Dec; 222(4):388-99. PubMed ID: 20922713
[TBL] [Abstract][Full Text] [Related]
7. Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?
Chollet P; Amat S; Belembaogo E; Curé H; de Latour M; Dauplat J; Le Bouëdec G; Mouret-Reynier MA; Ferrière JP; Penault-Llorca F
Br J Cancer; 2003 Oct; 89(7):1185-91. PubMed ID: 14520443
[TBL] [Abstract][Full Text] [Related]
8. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
9. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
11. Vascular grading of angiogenesis: prognostic significance in breast cancer.
Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
Br J Cancer; 2000 Jan; 82(2):339-47. PubMed ID: 10646886
[TBL] [Abstract][Full Text] [Related]
12. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
13. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
14. Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre.
Ong TA; Yip CH
Asian J Surg; 2003 Jul; 26(3):169-75. PubMed ID: 12925293
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
16. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
17. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.
Brain E; Garrino C; Misset JL; Carbonero IG; Itzhaki M; Cvitkovic E; Goldschmidt E; Burki F; Regensberg C; Pappo E; Hagipantelli R; Musset M
Br J Cancer; 1997; 75(9):1360-7. PubMed ID: 9155059
[TBL] [Abstract][Full Text] [Related]
19. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
20. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.
Bastarrachea J; Hortobagyi GN; Smith TL; Kau SW; Buzdar AU
Ann Intern Med; 1994 Jan; 120(1):18-25. PubMed ID: 8250452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
